Fit and well

Healthy Volunteer Collection

Year Started: 2018

Collection of samples from Healthy Volunteers alongside health questionnaire data

Access:
Open to applicants
Type:
Disease specific
Status:
In progress
Collection point:
Multiple points in patient pathway
Consent restrictions:
No restrictions


Male

Young adult (18 - 40 years)

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Plasma Liquid nitrogen Not applicable 26 - 50%
Saliva Liquid nitrogen Not applicable 75% -99%
Serum -60 °C to -85 °C Not applicable 26 - 50%
Serum Liquid nitrogen Not applicable 11 - 25%
Whole blood Liquid nitrogen Not applicable 26 - 50%


Female

Young adult (18 - 40 years)

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Plasma Liquid nitrogen Not applicable 26 - 50%
Saliva Liquid nitrogen Not applicable 100%
Serum -60 °C to -85 °C Not applicable 26 - 50%
Serum Liquid nitrogen Not applicable 26 - 50%
Whole blood Liquid nitrogen Not applicable 26 - 50%


Male

Adult (> 40 years)

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Plasma Liquid nitrogen Not applicable 75% -99%
Saliva Liquid nitrogen Not applicable 75% -99%
Serum -60 °C to -85 °C Not applicable 51 - 75%
Serum Liquid nitrogen Not applicable 51 - 75%
Whole blood Liquid nitrogen Not applicable 75% -99%


Female

Adult (> 40 years)

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Plasma Liquid nitrogen Not applicable 26 - 50%
Saliva Liquid nitrogen Not applicable 75% -99%
Serum -60 °C to -85 °C Not applicable 26 - 50%
Serum Liquid nitrogen Not applicable 26 - 50%
Whole blood Liquid nitrogen Not applicable 26 - 50%

Cystic fibrosis (disorder)

Cystic Fibrosis Collection

Year Started: 2020

Access:
Access restricted at present
Type:
Disease specific
Status:
In progress
Collection point:
Multiple points in patient pathway
Consent restrictions:
No restrictions


Male

Young adult (18 - 40 years)

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Serum -60 °C to -85 °C Not applicable 75% -99%
Whole blood -60 °C to -85 °C Not applicable 75% -99%
Sputum -60 °C to -85 °C Not applicable 11 - 25%


Male

Adult (> 40 years)

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Serum -60 °C to -85 °C Not applicable 100%
Whole blood -60 °C to -85 °C Not applicable 75% -99%
Sputum -60 °C to -85 °C Not applicable 51 - 75%


Female

Young adult (18 - 40 years)

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Serum -60 °C to -85 °C Not applicable 75% -99%
Whole blood -60 °C to -85 °C Not applicable 75% -99%
Sputum -60 °C to -85 °C Not applicable 11 - 25%


Female

Adult (> 40 years)

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Serum -60 °C to -85 °C Not applicable 100%
Whole blood -60 °C to -85 °C Not applicable 100%
Sputum -60 °C to -85 °C Not applicable 11 - 25%

Urinary tract infectious disease (disorder)

DUTY- Diagnosis of Urinary Tract infection in Young children

Year Started: 2010

The DUTY (Diagnosis of Urinary Tract infection in Young children) study was designed to improve the way in which doctors and nurses find out when a young child has a urine infection so that they can start effective treatment earlier.

Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Collection point:
Multiple points in patient pathway
Consent restrictions:
Commercial restriction, DNA restriction, Other animal work restriction, Xenograft restriction


Unknown

Neonate (0 - 1 month)

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Urine -60 °C to -85 °C Not applicable 100%


Unknown

Infant (1 month - 2 years)

3001 - 5000 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Urine -60 °C to -85 °C Not applicable 100%


Unknown

Young child (2 - 6 years)

1001 - 3000 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Urine -60 °C to -85 °C Not applicable 100%


Unknown

Data not recorded

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Urine -60 °C to -85 °C Not applicable 100%

Neurofibromatosis type 1 (disorder)

Neurofibromatosis Type 1 Collection

Year Started: 1990

Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Collection point:
Multiple points in patient pathway
Consent restrictions:
No restrictions


Unknown

Data not recorded

101 - 500 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Tissue -60 °C to -85 °C Not applicable 51 - 75%
Tissue Paraffin Not applicable 26 - 50%

Acute myeloid leukemia, disease (disorder)

AML 10 Clinical Trial Collection

Year Started: 1992

Samples from the AML 10 Clinical Trial

Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Collection point:
Post-diagnosis
Consent restrictions:
Other animal work restriction, Xenograft restriction


Male

Adolescent (12 - 18 years)

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Bone marrow mononuclear cells Liquid nitrogen Not applicable 100%


Male

Young adult (18 - 40 years)

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Bone marrow mononuclear cells Liquid nitrogen Not applicable 100%


Female

Young adult (18 - 40 years)

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Bone marrow mononuclear cells Liquid nitrogen Not applicable 100%


Female

Adult (> 40 years)

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Bone marrow mononuclear cells Liquid nitrogen Not applicable 100%

Acute myeloid leukemia, disease (disorder)

AML 11 Clinical Trial Collection

Year Started: 1992

Samples from the AML 11 Clinical Trial

Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Collection point:
Post-diagnosis
Consent restrictions:
Other animal work restriction, Xenograft restriction


Male

Adult (> 40 years)

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 26 - 50%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 51 - 75%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 26 - 50%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 51 - 75%

Acute myeloid leukemia, disease (disorder)

AML 12 Clinical Trial Collection

Year Started: 1995

Samples from the AML12 Clinical Trial

Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Collection point:
Post-diagnosis
Consent restrictions:
Other animal work restriction, Xenograft restriction


Male

Young adult (18 - 40 years)

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 51 - 75%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 26 - 50%


Male

Adult (> 40 years)

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 51 - 75%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 26 - 50%


Female

Adolescent (12 - 18 years)

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 26 - 50%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 51 - 75%


Female

Young adult (18 - 40 years)

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 51 - 75%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 51 - 75%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 51 - 75%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 26 - 50%

Acute myeloid leukemia, disease (disorder)

AML 14 Clinical Trial Collection

Year Started: 1999

Samples from the AML 14 clinical trial

Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Collection point:
Post-diagnosis
Consent restrictions:
Other animal work restriction, Xenograft restriction


Male

Adult (> 40 years)

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 75% -99%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 26 - 50%


Unknown

Adult (> 40 years)

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 75% -99%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 11 - 25%

Acute myeloid leukemia, disease (disorder)

AML 15 Clinical Trial Collection

Year Started: 2002

Samples from the AML 15 Clinical Trial

Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Collection point:
Post-diagnosis
Consent restrictions:
Other animal work restriction, Xenograft restriction


Male

Adolescent (12 - 18 years)

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 100%


Male

Young adult (18 - 40 years)

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 75% -99%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 51 - 75%


Male

Adult (> 40 years)

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 75% -99%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 0 - 10%


Male

Data not recorded

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 51 - 75%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 26 - 50%


Female

Young adult (18 - 40 years)

1 - 10 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 100%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 75% -99%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 26 - 50%


Unknown

Young adult (18 - 40 years)

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 75% -99%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 26 - 50%


Unknown

Adult (> 40 years)

101 - 500 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 75% -99%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 11 - 25%


Unknown

Data not recorded

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 75% -99%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 0 - 10%

Acute myeloid leukemia, disease (disorder)

AML 16 Clinical Trial Collection

Year Started: 2006

Samples from the AML 16 trial

Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Collection point:
Post-diagnosis
Consent restrictions:
Other animal work restriction, Xenograft restriction


Unknown

Adult (> 40 years)

101 - 500 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Peripheral blood cells Liquid nitrogen Not applicable 75% -99%
Bone marrow mononuclear cells Liquid nitrogen Not applicable 11 - 25%

Ulcer of foot due to diabetes mellitus (disorder)

INDUCE: Point-of-care tests to assist antibiotic prescribing decisions for diabetic foot ulcer infections

Year Started: 2014

Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Collection point:
Post-diagnosis
Consent restrictions:
Commercial restriction, DNA restriction, Other animal work restriction, Xenograft restriction


Unknown

Data not recorded

11 - 100 donors

Material Type Storage Temperature Macroscopic Assessment % of Sample Set
Serum -60 °C to -85 °C Not applicable 100%
Swabs -60 °C to -85 °C Not applicable 75% -99%
Swab Wash -60 °C to -85 °C Not applicable 75% -99%